274 related articles for article (PubMed ID: 20828575)
1. Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria.
McQuillan JA; Mitchell AJ; Ho YF; Combes V; Ball HJ; Golenser J; Grau GE; Hunt NH
Int J Parasitol; 2011 Feb; 41(2):155-63. PubMed ID: 20828575
[TBL] [Abstract][Full Text] [Related]
2. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
[TBL] [Abstract][Full Text] [Related]
3. Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response.
Wu JJ; Chen G; Liu J; Wang T; Zheng W; Cao YM
Parasitol Int; 2010 Jun; 59(2):232-41. PubMed ID: 20219695
[TBL] [Abstract][Full Text] [Related]
4. Cerebral malaria protection in mice by species-specific Plasmodium coinfection is associated with reduced CC chemokine levels in the brain.
Clark CJ; Phillips RS
Parasite Immunol; 2011 Nov; 33(11):637-41. PubMed ID: 21851365
[TBL] [Abstract][Full Text] [Related]
5. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria.
Haque A; Best SE; Unosson K; Amante FH; de Labastida F; Anstey NM; Karupiah G; Smyth MJ; Heath WR; Engwerda CR
J Immunol; 2011 Jun; 186(11):6148-56. PubMed ID: 21525386
[TBL] [Abstract][Full Text] [Related]
6. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria.
Amante FH; Haque A; Stanley AC; Rivera Fde L; Randall LM; Wilson YA; Yeo G; Pieper C; Crabb BS; de Koning-Ward TF; Lundie RJ; Good MF; Pinzon-Charry A; Pearson MS; Duke MG; McManus DP; Loukas A; Hill GR; Engwerda CR
J Immunol; 2010 Sep; 185(6):3632-42. PubMed ID: 20720206
[TBL] [Abstract][Full Text] [Related]
7. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
8. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
White KL; Snyder HL; Krzych U
J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
[TBL] [Abstract][Full Text] [Related]
9. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
Nie CQ; Bernard NJ; Schofield L; Hansen DS
Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
11. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.
Niikura M; Kamiya S; Nakane A; Kita K; Kobayashi F
Int J Parasitol; 2010 Jan; 40(1):101-8. PubMed ID: 19735663
[TBL] [Abstract][Full Text] [Related]
12. Filaria-induced IL-10 suppresses murine cerebral malaria.
Specht S; Ruiz DF; Dubben B; Deininger S; Hoerauf A
Microbes Infect; 2010 Aug; 12(8-9):635-42. PubMed ID: 20420933
[TBL] [Abstract][Full Text] [Related]
13. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria.
Potter S; Chan-Ling T; Ball HJ; Mansour H; Mitchell A; Maluish L; Hunt NH
Int J Parasitol; 2006 Apr; 36(4):485-96. PubMed ID: 16500656
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria.
Bucher K; Dietz K; Lackner P; Pasche B; Fendel R; Mordmüller B; Ben-Smith A; Hoffmann WH
Int J Parasitol; 2011 Jan; 41(1):21-31. PubMed ID: 20708623
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic T cells in cerebral malaria.
Rénia L; Potter SM; Mauduit M; Rosa DS; Kayibanda M; Deschemin JC; Snounou G; Grüner AC
Int J Parasitol; 2006 May; 36(5):547-54. PubMed ID: 16600241
[TBL] [Abstract][Full Text] [Related]
18. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
19. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
[TBL] [Abstract][Full Text] [Related]
20. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]